Stelara Injection 130 mg/26 ml

Stelara (Ustekinumab)

Ustekinumab under the trade name  Stelara (also known as CNTO 1275) is an immunosuppressant used to treat plaque psoriasis, psoriatic arthritis, and Crohn’s disease. Ustekinumab as the first biologic therapy for Crohn’s disease is the only treatment for Crohn’s disease that starts with a weight-based, one-time intravenous (IV) infusion induction dose.

Continue reading